OraSure Technologies elects Jack Kenny to the Board of Directors Page 1

BETHLEHEM, Pa., Sept. 9, 2024 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic testing and sample management solutions, today announced the election of Jack Kenny to the Company's Board of Directors, effective September 9, 2024. With the appointment of Mr. Kenny, OraSure's Board of Directors currently consists of seven members.

Mr. Kenny is the former CEO of Meridian Bioscience, where he led the company's turnaround prior to its acquisition. He has over 30 years of experience in senior leadership roles in the in vitro diagnostics, molecular biology and laboratory services industries. He will serve as a Class I Director, with his first term ending at OraSure's Annual General Meeting in 2025.